Case 1 - 2006 Off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: A patient with heparin-induced thrombocytopenia syndrome type II and renal failure

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 1, 2006, Pages 106-111

  Spiess, Bruce D ^a,e   DeAnda, Abe ^a   McCarthy, Harry L ^a   Yeatman, Douglas ^a   Katlaps, Gundar ^a   Cooper, Catherine ^a   Koster, Andreas ^b   Aldea, Gabriel S ^c   Gravlee, Glenn P ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulation; Bivalirudin; Coronary artery bypass graft surgery; Heparin induced thrombocytopenia; Hirudin; Thrombin inhibition

Indexed keywords

ANTICOAGULANT AGENT; HEMOGLOBIN; HEPARIN; HETASTARCH; HIRUDIN; HIRULOG;

AGED; ANASTOMOSIS; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING TIME; CASE REPORT; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HALF LIFE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART CATHETERIZATION; HEMOGLOBIN BLOOD LEVEL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; SAPHENOUS VEIN GRAFT; THORAX RADIOGRAPHY;

AGED; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HIRUDINS; HUMANS; KIDNEY FAILURE; MALE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SYNDROME; THROMBOCYTOPENIA;

EID: 31844437155     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.11.011     Document Type: Conference Paper

References (34)

1. B.D. Spiess Unfractionated heparin for cardiopulmonary bypass An unnatural act? J Cardiothorac Vasc Anesth 14 2000 239 242
2. A. Koster, R. Sodian, H. Kupp Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin Anesthesiology 89 1998 777 780
3. T.F. Slaughter, C.S. Greenberg Heparin-associated thrombocytopenia Implications for perioperative management Anesthesiology 87 1997 667 675
4. B. Potzsch, W.P. Klovekorn, K. Madlener Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia N Engl J Med 353 2000 515
5. T.L. Bauer, A. Gowthami, B.A. Konkle Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242 1246
6. J.H. Mudaliar, T.K. Liem, W.K. Nichols Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies J Vasc Surg 34 2001 17 20
7. P. Latham, A.F. Revelis, G.P. Joshi Use of recombinant hirudin in patients with heparin-induced thrombocytopenia type II with thrombosis requiring cardiopulmonary bypass Anesthesiology 92 2000 263 266
8. M.J. Wilhelm, C. Schmid, D. Kececioglu Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172 Ann Thorac Surg 61 1996 920 924
9. V.J. Zulys, S.J. Teasdale, E.R. Michel Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass Anesthesiology 71 1989 870 877
10. B.D. Spiess, T. Gernsheimer, C. Vocelka Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation J Cardiothorac Vasc Anesth 10 1996 918 921
11. H.N. Magnani Heparin-induced thrombocytopenia (HIT) An overview of 230 patients treated with Orgaran (Org 10172) Thromb Haemost 70 1993 554 561
12. A. Koster Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II A 1-year experience in 57 patients J Cardiothorac Vasc Anesth 14 2000 243 248
13. H. White Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction; The HERO-2 randomized trial Lancet 358 2001 1855 1863
14. R. Robson The use of bivalirudin in patients with renal impairment J Invasive Cardiol 12 suppl F 2000 33F 36F
15. A. Koster, M. Pasic, M. Bauer Recombinant hirudin as anticoagulant for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. Importance of preoperative renal function Ann Thor Surg 69 2000 37 41
16. D.F. Kong, E.J. Topol, J.A. Bittl Clinical outcomes of bivalirudin for ischemic heart disease Circulation 100 1999 2049 2053
17. M.A. Lincoff, J.A. Bittle, R.A. Harrington Bivalirudin and provisional glycoprotein IIb/IIa inhibition compared with heparin and glycoprotein IIb/IIa blockade during percutaneous coronary intervention REPLACE-2 randomized trial JAMA 289 2003 853 863
18. A. Merry, P.J. Raudkivi, N.G. Middelton Bivalirudin versus heparin and protamine during off pump coronary bypass surgery Ann Thorac Surg 77 2004 925 931
19. A. Koster, B. Spiess, D.P. Chew First pilot experience with the direct thrombin inhibitor bivalirudin as a replacement for heparin during cardiopulmonary bypass Am J Cardiol 93 2004 356 359
20. T.E. Warkentin, J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
21. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
22. R.T. Williams, L.V. Damaraju, M.A. Mascelli Anti-platelet factor 4/heparin antibodies An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes Circulation 107 2003 2307 2312
23. T.E. Warkentin, A.G. Greinbacher Heparin-induced thrombocytopenia Recognition, treatment and prevention Chest 126 2004 311S 337S
24. G.S. Aldea, M. Doursanian, P. O'Gara Heparin-bonded cardiopulmonary bypass circuits and a reduced anticoagulation protocol in patients undergoing primary CABG A prospective randomized study Ann Thorac Surg 62 1996 410 418
25. G.S. Aldea, L.O. Soltow, W.L. Chandler Limitation of thrombin generation, platelet activation and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits J Thorac Cardiovasc Surg 123 2002 742 755
26. M. Otaki, T. Enmoto, H. Oku Coronary artery grafting in patients dependent on dialysis Modified untrafiltration for perioperative management ASAIO J 49 2003 650 654
27. T.C. Koutlas, J.W. Gaynor, S.C. Nicolson Modified ultra-filtration reduces perioperative morbidity after cavopulmonary connection Ann Thorac Surg 64 1997 37 42
28. T.E. Warkentin, J.G. Kelton A 14-year study of heparin-induced thrombocytopenia Am J Med 101 1996 502 507
29. D.E. Wallis, D.L. Workman, B.E. Lewis Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 106 1999 629 635
30. B. Potzch, K. Madlener, C. Seelig Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass Assessment of the whole blood ecarin clotting time Thromb Haemost 77 1997 902 925
31. E. Pravinkumar, N.R. Webster HIT/HITT and alternative anticoagulation Current concepts Br J Anaesth 90 2003 676 685
32. G.N. Olinger, C.V. Hussey, J.A. Olive Cardiopulmonary bypass for patients with previously-documented heparin-induced platelet aggregation J Thorac Cardiovasc Surg 87 1984 673 677
33. T.E. Warkentin Clinical picture of heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia ed 3 2004 Marcel Dekker Inc New York, NY 53 106
34. T.E. Warkentin, A. Greinacher Laboratory testing for heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia ed 3 2004 Marcel Dekker Inc New York, NY 271 312